Group group

Group Lead: Prof Andrew Wilson

Activities and ethos of the group Activities and ethos of the group

We undertake clinical trials and clinical research in areas of Respiratory Medicine and Rhinology and ENT Surgery, with an emphasis on Asthma, Interstitial Lung Disease and disorders altering the sense of smell. Currently the group co-ordinates three National Clinical Trials with funding totalling £6.3M. The ARRISA-UK project is investigating the role of risk registers and their implementation in clinical practice, the EME-TIPAC study is investigating the efficacy of antibiotic therapy in people with idiopathic pulmonary fibrosis and the MACRO study is evaluating the effects of macrolide treatment in people with chronic rhino sinusitis. We also undertake studies looking at epidemiology, health related quality of life, exercise, and biomarkers, in a range of conditions affecting the respiratory tract in its widest sense.

key areas of research key areas of research

  • Interstitial Lung Disease
  • Asthma
  • Smell
  • Rhinitis and rhino sinusitis
  • Biomarkers
  • Exercise and activity

researchers researchers

Andrew Wilson

Carl Philpott

Dayle Terrington

Adam Peel

Sally Erskine

Eleanor Mishra

Mark Pasteur

Peter Prinsley

Jee Kim

Jennifer Whitty

external collaborators external collaborators

Asthma UK Centre for Applied Research (AUKCAR)

Macro Programme Grant Team

University of Manchester